These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36902065)

  • 21. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of right coronary vascular dysfunction in severe pulmonary hypertensive rats using synchrotron radiation microangiography.
    Inagaki T; Pearson JT; Tsuchimochi H; Schwenke DO; Saito S; Higuchi T; Masaki T; Umetani K; Shirai M; Nakaoka Y
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1021-H1036. PubMed ID: 33481696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive protective effects of sacubitril/valsartan and bosentan on vascular remodelling in experimental pulmonary hypertension.
    Chaumais MC; Djessas MRA; Thuillet R; Cumont A; Tu L; Hebert G; Gaignard P; Huertas A; Savale L; Humbert M; Guignabert C
    Cardiovasc Res; 2021 Apr; 117(5):1391-1401. PubMed ID: 32653925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ranolazine prevents INaL enhancement and blunts myocardial remodelling in a model of pulmonary hypertension.
    Rocchetti M; Sala L; Rizzetto R; Staszewsky LI; Alemanni M; Zambelli V; Russo I; Barile L; Cornaghi L; Altomare C; Ronchi C; Mostacciuolo G; Lucchetti J; Gobbi M; Latini R; Zaza A
    Cardiovasc Res; 2014 Oct; 104(1):37-48. PubMed ID: 25139747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of miR-335-5p Contributes to Right Ventricular Remodeling via Calumenin in Pulmonary Arterial Hypertension.
    Ma H; Ye P; Zhang AK; Yu WD; Lin S; Zheng YG
    Biomed Res Int; 2022; 2022():9294148. PubMed ID: 36246958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colchicine Depolymerizes Microtubules, Increases Junctophilin-2, and Improves Right Ventricular Function in Experimental Pulmonary Arterial Hypertension.
    Prins KW; Tian L; Wu D; Thenappan T; Metzger JM; Archer SL
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intermittent Fasting Enhances Right Ventricular Function in Preclinical Pulmonary Arterial Hypertension.
    Prisco SZ; Eklund M; Moutsoglou DM; Prisco AR; Khoruts A; Weir EK; Thenappan T; Prins KW
    J Am Heart Assoc; 2021 Nov; 10(22):e022722. PubMed ID: 34747187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
    Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
    Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuregulin-1 attenuates right ventricular diastolic stiffness in experimental pulmonary hypertension.
    Adão R; Mendes-Ferreira P; Maia-Rocha C; Santos-Ribeiro D; Rodrigues PG; Vidal-Meireles A; Monteiro-Pinto C; Pimentel LD; Falcão-Pires I; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):255-265. PubMed ID: 30339273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Energy Metabolism in the Failing Right Ventricle: Limitations of Oxygen Delivery and the Creatine Kinase System.
    Fowler ED; Hauton D; Boyle J; Egginton S; Steele DS; White E
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.
    Lu M; Chen LY; Gairhe S; Mazer AJ; Anderson SA; Nelson JNH; Noguchi A; Siddique MAH; Dougherty EJ; Zou Y; Johnston KA; Yu ZX; Wang H; Wang S; Sun J; Solomon SB; Vanderpool RR; Solomon MA; Danner RL; Elinoff JM
    Am J Physiol Lung Cell Mol Physiol; 2022 Mar; 322(3):L315-L332. PubMed ID: 35043674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right predominant electrical remodeling in a pure model of pulmonary hypertension promotes reentrant arrhythmias.
    Strauss B; Bisserier M; Obus E; Katz MG; Fargnoli A; Cacheux M; Akar JG; Hummel JP; Hadri L; Sassi Y; Akar FG
    Heart Rhythm; 2022 Jan; 19(1):113-124. PubMed ID: 34563688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
    Chen S; Sun P; Li Y; Shen W; Wang C; Zhao P; Cui H; Xue JY; Du GQ
    Eur J Pharmacol; 2022 Oct; 933():175262. PubMed ID: 36100129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPM4 Modulates Right Ventricular Remodeling Under Pressure Load Accompanied With Decreased Expression Level.
    Frede W; Medert R; Poth T; Gorenflo M; Vennekens R; Freichel M; Uhl S
    J Card Fail; 2020 Jul; 26(7):599-609. PubMed ID: 32147520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension.
    Vanderpool RR; Gorelova A; Ma Y; Alhamaydeh M; Baust J; Shiva S; Tofovic SP; Hu J; Nouraie SM; Gladwin MT; Sharifi-Sanjani M; Al Ghouleh I
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628236
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure.
    Hautbergue T; Antigny F; Boët A; Haddad F; Masson B; Lambert M; Delaporte A; Menager JB; Savale L; Pavec JL; Fadel E; Humbert M; Junot C; Fenaille F; Colsch B; Mercier O
    Cells; 2021 Jun; 10(6):. PubMed ID: 34205639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stabilization of RyR2 maintains right ventricular function, reduces the development of ventricular arrhythmias, and improves prognosis in pulmonary hypertension.
    Tanaka S; Yamamoto T; Mikawa M; Nawata J; Fujii S; Nakamura Y; Kato T; Fukuda M; Suetomi T; Uchinoumi H; Oda T; Okuda S; Okamura T; Kobayashi S; Yano M
    Heart Rhythm; 2022 Jun; 19(6):986-997. PubMed ID: 35134547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.